Bruker Introduces ParaVision® 360 Preclinical Imaging Software and AVANCE® NEO Systems with Advanced Multi-Receive Architecture for MRI

PARIS, June 18, 2018 /PRNewswire/ — At the International Society of Magnetic Resonance in Medicine Conference (www.ismrm.org), Bruker announced the launch of the next version of its preclinical imaging software, ParaVision 360.  It is the most advanced research-grade software for preclinical MRI, and has now also been extended to nuclear molecular imaging.  ParaVision 360 enables sequential... Read more

Thermo Fisher Scientific Launches Ion AmpliSeq HD Technology

New library preparation solution for targeted next-generation sequencing is first to combine gene panel design customization with ultra-high sensitivity CARLSBAD, Calif., June 18, 2018 /PRNewswire/ — Thermo Fisher Scientific today announced the launch of its Ion AmpliSeq HD technology, the latest next-generation library preparation innovation that, for the first time, provides clinical researchers with the... Read more

New long-term data confirm Roche’s Gazyva/Gazyvaro extends the lives of people with chronic lymphocytic leukaemia compared to MabThera/Rituxan

Basel, 15 June 2018 New long-term data confirm Roche’s Gazyva/Gazyvaro extends the lives of people with chronic lymphocytic leukaemia compared to MabThera/Rituxan After a follow-up time of nearly five years the CLL11 study shows a 51% reduction in the risk of disease progression or death with Gazyva/Gazyvaro compared to MabThera/Rituxan The final analysis reports a... Read more

New long-term data confirm Roche’s Gazyva/Gazyvaro extends the lives of people with chronic lymphocytic leukaemia compared to MabThera/Rituxan

Basel, 15 June 2018 New long-term data confirm Roche’s Gazyva/Gazyvaro extends the lives of people with chronic lymphocytic leukaemia compared to MabThera/Rituxan After a follow-up time of nearly five years the CLL11 study shows a 51% reduction in the risk of disease progression or death with Gazyva/Gazyvaro compared to MabThera/Rituxan The final analysis reports a... Read more

Roche announces new OCREVUS (ocrelizumab) data on long-term disability benefits in primary progressive multiple sclerosis and initiation of two global studies in progressive multiple sclerosis

Basel, 14 June 2018 Roche announces new OCREVUS (ocrelizumab) data on long-term disability benefits in primary progressive multiple sclerosis and initiation of two global studies in progressive multiple sclerosis OCREVUS may delay the need for a wheelchair by seven years for people with primary progressive multiple sclerosis (PPMS) Longer-term efficacy and safety data are consistent... Read more

Bruker Introduces New SKYSCAN 2214 Ultra-High Resolution Nano-CT

BILLERICA, Mass., June 12, 2018 /PRNewswire/ — Bruker today announced the launch of the SKYSCAN™ 2214, a multiscale X-ray nano-CT (computed tomography) system with a unique X-ray source and detector geometry that generates sharper images with outstanding precision. The SKYSCAN 2214 offers unprecedented, ultra-high resolution for larger fields of view in larger objects, which makes nano-CT... Read more

Bruker Introduces New SKYSCAN 2214 Ultra-High Resolution Nano-CT

BILLERICA, Mass., June 12, 2018 /PRNewswire/ — Bruker today announced the launch of the SKYSCAN™ 2214, a multiscale X-ray nano-CT (computed tomography) system with a unique X-ray source and detector geometry that generates sharper images with outstanding precision. The SKYSCAN 2214 offers unprecedented, ultra-high resolution for larger fields of view in larger objects, which makes nano-CT... Read more